The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis

被引:27
作者
Chen, Peng [2 ]
Wang, Shao-jin [2 ]
Wang, Hong-bo [2 ]
Ren, Peng [2 ]
Wang, Xi-qian [2 ]
Liu, Wen-guang [2 ]
Gu, Wan-li [2 ]
Li, Dong-qing [2 ]
Zhang, Ting-guo [3 ]
Zhou, Cheng-jun [1 ]
机构
[1] Shandong Univ, Hosp 2, Dept Pathol, Jinan 250033, Shandong, Peoples R China
[2] Shandong Univ, Hosp 2, Dept Osteol, Jinan 250033, Shandong, Peoples R China
[3] Shandong Univ, Dept Pathol, Sch Med, Jinan 250012, Shandong, Peoples R China
关键词
Osteosarcoma; IGF2; IMP3; Angiogenesis; GROWTH-FACTOR-I; HUMAN-BREAST-CANCER; ENDOTHELIAL-CELLS; FACTOR RECEPTOR; TUMOR LYMPHANGIOGENESIS; CARCINOMA CELLS; BINDING-PROTEIN; MESSENGER-RNA; EXPRESSION; METASTASIS;
D O I
10.1007/s10735-011-9370-2
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
The aim of this study was to investigate the expression patterns of IGF2 and IMP3 in osteosarcoma as well as its relationship with angiogenesis in the tumor. IGF2 and IMP3 expression was detected by immunohistochemical staining in the serial sections of the osteosarcoma. The impacts of IGF2 and IMP3 expression patterns on tumor angiogenesis were evaluated by statistics. The IGF2 and IMP3 staining had different expression patterns in different osteosarcoma. Twelve out of the sixty-four cases of conventional osteosarcoma showed nuclear staining patterns, and twenty-nine showed cytoplasmic staining of IGF2 and IMP3 simultaneously. On the other hand, fourteen cases showed nuclear IGF2 staining but cytoplasmic IMP3 expression, and nine cases showed nuclear IMP3 staining and cytoplasmic IGF2 expression. Twenty-eight out of forty-seven cases of parosteal osteosarcoma showed nuclear IGF2 and IMP3 expression, nine showed cytoplasmic IGF2 and IMP3 expression simultaneously. Seven out of forty-seven cases of parosteal osteosarcoma expressed IGF2 with nuclear staining but expressed IMP3 with cytoplasmic staining. Meanwhile, three cases expressed IGF2 with cytoplasmic staining but expressed IMP3 with nuclear staining. Similar to the parosteal osteosarcoma, the periosteal osteosarcoma expressed IGF2 and IMP3 mainly with nuclear staining simultaneously, forty out of fifty-five cases of periosteal osteosarcoma did that. Five out of fifty-five cases expressed IGF2 and IMP3 with cytoplasmic staining at the same time. Four cases showed nuclear IGF2 staining and cytoplasmic IMP3 staining. In the parosteal and periosteal osteosarcoma, there was no significant difference in IGF and IMP3 expression patterns (P = 0.216). However, compared with conventional osteosarcoma, the parosteal and periosteal osteosarcoma showed significant difference in IMP3 and IGF2 expression (P = 0.016, P = 0.023). IGF2 and IMP3 expression patterns were positive correlation in the different osteosarcoma (r = 0.1021, P = 0.032). The Microvessel density (MVD) in osteosarcoma with IGF2 and IMP3 cytoplasmic staining was more than that with nuclear expression of IGF2 and IMP3, and the difference was significant (P = 0.024). Moreover, the conventional osteosarcoma with cytoplasmic IGF and IMP3 showed more MVD than parosteal and periosteal osteosarcoma with cytoplasmic IGF and IMP3, and the difference was significant (P = 0.035). IGF2 and IMP3 had different expression patterns, which might be associated with angiogenesis. However, cytoplasmic and nuclear expression of IGF2 and IMP3 might play different roles in the angiogenesis of osteosarcoma.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 48 条
[1]
Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation [J].
Al-Romaih, Khaldoun ;
Somers, Gino R. ;
Bayani, Jane ;
Hughes, Simon ;
Prasad, Mona ;
Cutz, Jean-Claude ;
Xue, Hui ;
Zielenska, Maria ;
Wang, Yuzhuo ;
Squire, Jeremy A. .
CANCER CELL INTERNATIONAL, 2007, 7 (1)
[2]
Molecular mechanisms of lymphangiogenesis in health and disease [J].
Alitalo, K ;
Carmeliet, P .
CANCER CELL, 2002, 1 (03) :219-227
[3]
Amit D, 2011, INT J CLIN EXP MED, V4, P91
[4]
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma [J].
Avnet, Sofia ;
Sciacca, Laura ;
Salerno, Manuela ;
Gancitano, Giovanni ;
Cassarino, Maria Francesca ;
Longhi, Alessandra ;
Zakikhani, Mahvash ;
Carboni, Joan M. ;
Gottardis, Marco ;
Giuti, Armando ;
Pollak, Michael ;
Vigneri, Riccardo ;
Baldini, Nicola .
CANCER RESEARCH, 2009, 69 (06) :2443-2452
[5]
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[6]
The IGF-I receptor in cell growth, transformation and apoptosis [J].
Baserga, R ;
Hongo, A ;
Rubini, M ;
Prisco, M ;
Valentinis, B .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (03) :F105-F126
[7]
ISOLATION OF A NOVEL INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING-PROTEIN FROM HUMAN BONE - A POTENTIAL CANDIDATE FOR FIXING IGF-II IN HUMAN BONE [J].
BAUTISTA, CM ;
BAYLINK, DJ ;
MOHAN, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (02) :756-763
[8]
Beasley NJP, 2002, CANCER RES, V62, P1315
[9]
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo [J].
Björndahl, M ;
Cao, RH ;
Nissen, LJ ;
Clasper, S ;
Johnson, LA ;
Xue, Y ;
Zhou, ZJ ;
Jackson, D ;
Hansen, AJ ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15593-15598
[10]
Opinion - Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis [J].
Cao, YH .
NATURE REVIEWS CANCER, 2005, 5 (09) :735-743